Prevalence of inapropriate LDL cholesterol levels in patients with coronary disease and/or type 2 diabetes

被引:26
|
作者
Perez de Isla, L. [1 ]
Saltijeral Cerezo, A. [2 ]
Vitale, G. [3 ]
Gonzalez Timon, B. [3 ]
Torres Do Rego, A. [4 ]
Alvarez-Sala Walther, L. A. [4 ]
机构
[1] Hosp Clin San Carlos, Serv Cardiol, Madrid, Spain
[2] Hosp Tajo, Serv Cardiol, Madrid, Spain
[3] MSD Espana, Dept Med Merck Sharp & Dohme, Madrid, Spain
[4] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Unidad Riesgo Cardiovasc & Lipidos, Inst Invest Sanitarias,Fac Med,Red RECAVA, Madrid, Spain
来源
REVISTA CLINICA ESPANOLA | 2012年 / 212卷 / 10期
关键词
Hypercholesterolaemia; Cardiovascular risk factors; Metabolic syndrome; Cardiovascular risk control; HIGH-DENSITY-LIPOPROTEIN; ACUTE MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; RISK-FACTORS; SECONDARY PREVENTION; MORTALITY;
D O I
10.1016/j.rce.2012.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Clinical practice guidelines recommend achieving concentrations of LDL cholesterol less than 100 mg/dl (and in some cases less than 70 mg/dl) in patients with coronary artery disease and/or diabetes mellitus type 2 (DM2). We have examined the compliance with these objectives in patients treated in Spain with these conditions. Methods: Cross-sectional epidemiological study. Data were obtained during the visit of the study or, in their absence, based on data contained in the medical record by 874 doctors of the 17 autonomous communities in Spain. Demographic information, risk factors, cardiovascular and prescribed treatments were collected. Results: In the final analysis 6.988 (62.7% male) patients were included. 2586 (37%) had coronary disease, 2654 (38%) DM2 and 1748 (25%) both conditions. 65% had metabolic syndrome. Vascular risk factors median number was 4. 57% and 86% showed a concentration of LDL cholesterol > 100 and >70 mg/dl respectively. The proportion patients with LDL concentration >100 mg/dl was 4% greater in the DM2 (62.4%) than in coronary patients (57.1%; p 0.0001). Concentration of triglycerides > 150 mg/dl was higher in patients with DM2 (50.5%) than in coronary patients (43.5%; p 0.0001). The proportion of patients with LDL > 70 mg/dl was similar in the coronary group and in the DM2 Group (88.4% and 87.0%, respectively). More than half of patients with coronary heart disease (57.5%) or DM2 (55.7%) showed inadequate levels of HDL (< 40 mg/dl men; <50 mg/dl women). Conclusions: More than a half of patients with diabetes mellitus and/or coronary artery disease enrolled in the CODIMET study do not achieve the recommended LDL cholesterol target for high cardiovascular risk patients. (c) 2012 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:475 / 481
页数:7
相关论文
共 50 条
  • [21] Type 2 Diabetes is a Strong Predictor for LDL Cholesterol Target Achievement in Patients With Peripheral Artery Disease
    Sternbauer, Simon
    Vonbank, Alexander
    Heinzle, Christine
    Zanolin-Purin, Daniela
    Dopheide, Joern F.
    Baumgartner, Iris
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    CIRCULATION, 2019, 140
  • [22] Circulating oxidized LDL and antibodies against oxidized LDL in type 2 diabetes patients with and without coronary artery disease
    Gelisgen, R.
    Cimen, B.
    Yumuk, V.
    Bolayirli, M.
    Hacibekiroglu, M.
    Burcak, G.
    FEBS JOURNAL, 2007, 274 : 265 - 265
  • [23] Reasons for declining LDL-Cholesterol levels in patients with diabetes
    Selby, J
    Narayan, V
    Karter, A
    Swain, B
    Ferrara, A
    DIABETES, 2001, 50 : A1 - A1
  • [24] LDL-CHOLESTEROL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Tudor, C.
    Iana, A.
    Jeberean, R. A.
    Petrus, A.
    Buzas, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 33 - 34
  • [25] Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes
    Xu, Tao
    Brandmaier, Stefan
    Messias, Ana C.
    Herder, Christian
    Draisma, Harmen H. M.
    Demirkan, Ayse
    Yu, Zhonghao
    Ried, Janina S.
    Haller, Toomas
    Heier, Margit
    Campillos, Monica
    Fobo, Gisela
    Stark, Renee
    Holzapfel, Christina
    Adam, Jonathan
    Chi, Shen
    Rotter, Markus
    Panni, Tommaso
    Quante, Anne S.
    He, Ying
    Prehn, Cornelia
    Roemisch-Margl, Werner
    Kastenmueller, Gabi
    Willemsen, Gonneke
    Pool, Rene
    Kasa, Katarina
    van Dijk, Ko Willems
    Hankemeier, Thomas
    Meisinger, Christa
    Thorand, Barbara
    Ruepp, Andreas
    de Angelis, Martin Hrabe
    Li, Yixue
    Wichmann, H. -Erich
    Stratmann, Bernd
    Strauch, Konstantin
    Metspalu, Andres
    Gieger, Christian
    Suhre, Karsten
    Adamski, Jerzy
    Illig, Thomas
    Rathmann, Wolfgang
    Roden, Michael
    Peters, Annette
    van Duijn, Cornelia M.
    Boomsma, Dorret I.
    Meitinger, Thomas
    Wang-Sattler, Rui
    DIABETES CARE, 2015, 38 (10) : 1858 - 1867
  • [26] Increased platelet Fc receptor expression in diabetes is limited to those with type 2 disease and low LDL cholesterol levels
    Calverley, DC
    Baldermann, LV
    Heldt, ML
    Kinney, GL
    Hokanson, JE
    ATHEROSCLEROSIS, 2006, 185 (01) : 173 - 176
  • [27] Circulating levels of oxidized LDL in Type 2 diabetes patients.
    Hedlöf, E
    Lindstedt, P
    Bates, HM
    Lindgren, E
    DIABETOLOGIA, 2002, 45 : A386 - A386
  • [28] Provability of controlled LDL levels in patients with type 2 diabetes mellitus
    Echevarria, Marines Castillo
    Schmitt, Jessica
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 3): : 104 - 105
  • [29] Cholesterol and glycemia levels in Tunisian patients with type 2 diabetes
    Khliti, S.
    Ben Hmad, H.
    Serairi, R.
    Abid, A.
    Gmira, F.
    Aouidet, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 102 - 102
  • [30] Oxidized LDL in middle-aged type 2 diabetes patients without coronary heart disease
    Caparevic, Z
    Begovic, D
    Petrovic, D
    Spasic, S
    Cvetkovic, R
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 111 - 112